U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054775) titled 'Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section' on June 27.
Brief Summary: This study compares the incidence of pruritus (itching) requiring treatment between two doses of intrathecal morphine (0.1 mg vs 0.2 mg) when used for spinal anesthesia during cesarean section. The study aims to determine if the lower dose (0.1 mg) can reduce pruritus incidence while maintaining adequate pain relief.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Pruritus Caused by Drug
Intervention:
DRUG: Morphine Sulfate
intrathecal administered morphine
Recruitment Status: RECRUITING
S...